Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
Robert Zivadinov(Yale University), Omar Khan(Wayne State University), Olaf Stüve(Southwestern Medical Center), Michael G. Dwyer(Buffalo Psychiatric Center), Hans Lassmann(University of Vienna), Massimo Filippi(Vita-Salute San Raffaele University), Anthony T. Reder(University of Chicago), Alireza Minagar(Imam Khomeini Hospital), Elliot M. Frohman(The University of Texas Southwestern Medical Center), Michael K. Racke(The University of Texas Southwestern Medical Center)
Cited by 261
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k